« Previous
Next »
Contraception
Volume 81, Issue 6
, Pages
501-509
, June 2010
Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen
To access this article, please choose from the options below
☆ Conflict of interest statement: Professor Brucker is a member of an advisory board on 0.02 mg EE/2 mg CMA sponsored by Grünenthal GmbH, Aachen, Germany.
PII: S0010-7824(10)00012-0
doi: 10.1016/j.contraception.2010.01.011
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
Contraception
Volume 81, Issue 6
, Pages
501-509
, June 2010
